Cyclopharm Ltd (CYC) - Medical Equipment - Deals and Alliances Profile

Cyclopharm Ltd (CYC) - Medical Equipment - Deals and Alliances Profile


  • Products Id :- GDME82495D
  • |
  • Pages: 25
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Summary

Cyclopharm Ltd (Cyclopharm) is a radiopharmaceutical company that manufactures medical and healthcare equipment and components in the nuclear medicine business. The company's products include Technegas, a lung imaging device used to diagnose the presence of blood clots in the lungs; and positron emission tomography (PET) radiopharmaceuticals. The company is evaluating Technegas in new indications such as chronic obstructive pulmonary disease (COPD) and lung cancer. Cyclopharm operates a joint venture, Macquarie Medical Imaging, which provides diagnostic imaging services such as 3T MRI, CT, X-ray, ultrasound and positron emission tomography (PET) scanning. The company harnesses its Ultralute technology, which extends the life of Molybdenum-99 generators. It operates in Asia Pacific, Canada, Latin America, Europe and Germany. Cyclopharm is headquartered in New South Wales, Australia.

Cyclopharm Ltd (CYC)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.



Read More



Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications

+91-9015378249

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Cyclopharm Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cyclopharm Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cyclopharm Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cyclopharm Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Cyclopharm Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cyclopharm Ltd, Medical Equipment, Deal Details 10

Partnerships 10

Cyclopharm Enters into Partnership with Canadian Association of Nuclear Medicine 10

Cyclopharm Plans To Enter Into Commercialization Agreement For Ultralute Technology 11

Equity Offering 12

Cyclopharm Raises up to USD5.2 Million in Rights Offering of Shares 12

Cyclopharm Completes Rights Issue Of Shares For USD 1 Million 14

Acquisition 15

Cyclopharm to Acquire IC Medical Inter Commerce Medical 15

Cyclopharm Ltd-Key Competitors 16

Cyclopharm Ltd-Key Employees 17

Cyclopharm Ltd-Locations And Subsidiaries 18

Head Office 18

Other Locations & Subsidiaries 18

Joint Venture 19

Recent Developments 20

Financial Announcements 20

Aug 08, 2018: Cyclopharm 2018 first half preliminary headline update 20

Feb 06, 2017: Cyclopharm 2016 Preliminary Headline Update-Record Results 22

Product News 23

Aug 18, 2017: Nuclear imaging trial aiming to clear up airway diagnosis 23

Appendix 25

Methodology 25

About GlobalData 25

Contact Us 25

Disclaimer 25

List of Figures

Cyclopharm Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Cyclopharm Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Cyclopharm Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Cyclopharm Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Cyclopharm Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cyclopharm Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Cyclopharm Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cyclopharm Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

List of Tables

Cyclopharm Ltd, Medical Equipment, Key Facts, 2016 2

Cyclopharm Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Cyclopharm Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cyclopharm Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cyclopharm Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cyclopharm Ltd, Deals By Market, 2012 to YTD 2018 8

Cyclopharm Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cyclopharm Enters into Partnership with Canadian Association of Nuclear Medicine 10

Cyclopharm Plans To Enter Into Commercialization Agreement For Ultralute Technology 11

Cyclopharm Raises up to USD5.2 Million in Rights Offering of Shares 12

Cyclopharm Completes Rights Issue Of Shares For USD 1 Million 14

Cyclopharm to Acquire IC Medical Inter Commerce Medical 15

Cyclopharm Ltd, Key Competitors 16

Cyclopharm Ltd, Key Employees 17

Cyclopharm Ltd, Subsidiaries 18

Cyclopharm Ltd, Joint Venture 19

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com
 

Cyclopharm Ltd, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

select a license
Single User License
USD 250 INR 17948
Site License
USD 500 INR 35895
Corporate User License
USD 750 INR 53843

NEWSLETTER BY CATEGORY




Testimonials

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

An excellent provider. Thorough, precise and outstanding insight. They drill down to what we need and their reports are effective at integrating text with supporting graphics and charts. Their reports are a great resource to go back too. ...

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process....

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed...



Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India

download

Company Brochure

Engage with Us

sales [@] kenresearch.com